1.
患者基本临床资料
General clinical data of the patients in different groups (Mean±SD)
| Variables | Control group (n=20) | UAPgroup (n=20) | AMI group (n=20) | F or χ2 | P |
| *P < 0.05 vs control; #P < 0.05 vs UAP. | |||||
| Age (year) | 58.00±6.33 | 62.70±9.71 | 60.60±9.01 | 1.54 | 0.222 |
| BMI (kg/m2) | 25.39±1.86 | 26.43±2.12 | 25.99±1.94 | 1.40 | 0.256 |
| Male (n) | 11 | 14 | 16 | 2.88 | 0.237 |
| Smoking (n) | 4 | 4 | 6 | 0.73 | 0.693 |
| Family history (n) | — | 5 | 6 | - | - |
| Hypertension (n) | — | 8 | 11 | - | - |
| WBC (×109/L) | 6.18±1.18 | 6.38±1.34 | 11.48±3.09*# | 42.59 | 0.000 |
| Mononuclear cell (×109/L) | 0.43±0.09 | 0.45±0.18 | 0.54±0.33 | 1.44 | 0.245 |
| TC (mmol/L) | 4.33±0.80 | 4.42±1.36 | 4.47±1.16 | 0.82 | 0.921 |
| TG (mmol/L) | 1.66±0.96 | 2.11±1.25 | 1.46±0.70# | 2.19 | 0.121 |
| HDL (mmol/L) | 1.07±0.18 | 0.96±0.26 | 1.10±0.27 | 2.01 | 0.144 |
| LDL (mmol/L) | 2.21±0.61 | 2.48±1.06 | 2.53±0.79 | 0.81 | 0.450 |
| Apo A (g/L) | 1.22±0.22 | 1.20±0.22 | 1.17±0.20 | 0.31 | 0.732 |
| Apo B (g/L) | 0.83±0.23 | 0.83±0.35 | 0.82±0.27 | 0.01 | 0.988 |
| LPA (mg/L) | 128.15±125.79 | 385.45±370.13* | 423.25±370.08* | 5.34 | 0.007 |
| Uric acid (μmo1/L) | 295.85±64.32 | 337.10±80.21 | 278.60±61.61 | 3.77 | 0.029 |
| AST (U/L) | 21.35±3.82 | 24.25±6.70 | 98.7±103.42*# | 31.11 | 0.000 |
| ALT (U/L) | 19.00±7.53 | 25.50±18.33 | 42.05±14.90*# | 13.78 | 0.000 |
| LDH (U/L) | 170.95±26.15 | 167.15±30.15 | 902.95±587.97*# | 31.02 | 0.000 |
| CK (U/L) | 97.50±37.28 | 129.35±41.39 | 911.80±1529.07*# | 5.45 | 0.007 |
| CK-MB (U/L) | 13.90±4.46 | 14.6±4.07 | 85.10±124.04*# | 6.51 | 0.003 |
| CTnI (μg/L) | 0.01±0.01 | 0.04±0.06 | 8.05±15.74*# | 5.20 | 0.08 |